Delivery Order SPE2DB22D2206-SPE2DB25FJB40
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,758.08 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed price delivery order was awarded competitively on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used in the treatment of osteoporosis and bone-related...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a $20,336.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections), a pharmaceutical product used to treat osteoporosis. The contract was competitively awarded without set-aside designation and has an ultimate completion date of July 22, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- AmerisourceBergen Drug Corp was awarded a $54,516.23 delivery order contract by the Defense Logistics Agency on July 22, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). The contract is set to be completed by July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). The contract, valued at $2,601.43, is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,581.76 contract is for the delivery of Forteo 560 MCG/2.24 ML Pen Inj 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This delivery order, valued at $5,202.86, represents a competitive award to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) to support federal healthcare needs. Issued by the Defense Logistics Agency on July 22, 2025, with completion expected by July 23, 2025, the contract utilizes firm fixed pricing and carries no set-aside designation. The pharmaceutical product will be delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract is a firm-fixed-price delivery order with a ceiling value of $1,001.58 and a period of performance through June 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJB40Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,190.02 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment commonly prescribed for osteoporosis management, representing one of the specialized pharmaceutical products within AmerisourceBergen's extensive federal medical procurement portfolio. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, maintains its position as a critical vendor for Defense Health Agency and other government healthcare systems through competitively awarded contracts with consistent firm fixed-price delivery order structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/24/25 |